Sorrento Therapeutics Common Stock

Sorrento Therapeutics (SRNE) currently reports a common stock of $55K as of June 2023. That compares with $18K in the prior-year period — up 205.6% year over year. Use the charts on this page to explore Sorrento Therapeutics's common stock history and peer comparisons.

Sorrento Therapeutics's common stock increased from $18K to $55K — a 205.6% year-over-year increase (period ending June 2023). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Sorrento Therapeutics reported $55K in common stock as of June 2023. That compares with $18K in the prior-year period — up 205.6% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current common stock of $55K, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Sorrento Therapeutics, and consider following SRNE for alerts when major investors trade the stock.

Sorrento Therapeutics is classified in the Healthcare sector. On common stock, it currently shows $55K. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing SRNE with unrelated industries.